The Upgrade Question, Answered Honestly Retatrutide is almost certainly going to be the more powerful drug when head-to-head data eventually arrives
But this exclusion remains embedded in permanent Part D law after the Bridge expires, the structural barrier returns unless Congress acts
However, one fact matters most: retatrutide is not FDA-approved yet
Back Carlsson, LMS, Carlsson, B, Jacobson, P, et al (12 July 2023) 'Life expectancy after bariatric surgery or usual care in patients with or without baseline type 2 diabetes in Swedish obese subjects', International Journal of Obesity (London) , 47/10
You have several options to find relief
Ultimately, the decision to pursue specific interventions should be made in consultation with your healthcare provider, carefully weighing individual health factors, potential risks and benefits, and treatment goals